Copyright Year 2023

Edition Number  1

ISBN Number 9780323829380

Book

Page Count 384

DESCRIPTION

Offering a one-stop guide to recognition and therapeutic decision making, Diagnosis and Treatment of Rare Gynecologic Cancers fills a gap in the medical literature on uncommon ovarian, uterine, cervical, and vulvovaginal cancers and trophoblastic diseases.

This authoritative text, edited by Drs. Michael Frumovitz, Mario Leitao, and Preetha Ramalingam, has been authored by internationally recognized experts from top institutions such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Each chapter covers different cancer subtypes and has been reviewed by an oncologist and a pathologist. 

Key Features

• Provides up-to-date clinical guidance on assessment and therapeutic options for patients with rare gynecologic malignancies.

• Presents information in a templated, easy-to-read format. Each chapter includes an introductory clinical case followed by epidemiology of disease, pathologic assessment, basic science/molecular/translational research, work-up of newly diagnosed disease, staging, treatment of newly diagnosed disease, treatment of recurrent disease, potential therapeutic targets, and a case resolution.

• Includes diagnostic and treatment algorithms for each form of cancer.

• Contains numerous anatomical figures, radiographs, photographs, and tables for quick visual reference.

• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

TABLE OF CONTENTS

Contributor Information: Please list names/affiliations of any contributors (can be tentative):

Section 1 – Ovarian Cancer

Malignant Germ Cell Tumors

Sex Cord-Stromal Tumors

Malignant Mixed Mesodermal Tumor

Clear Cell Carcinoma

Mucinous Carcinomas

Low-Grade Serous Tumors (MPSC) and Variants

Small Cell (hypercalcemic)

Other rare ovarian cancers (Small Cell Carcinoma (hypercalcemic), Small Cell Carcinoma (Neuroendocrine, Mesolthelioma, Squamous Cell, Sarcomas)

Section 2 – Uterine Cancer

Leiomyosarcoma

Other sarcomas of the uterus (Endometrial Stromal Sarcoma, STUMP, adenosarcoma)

Carcinosarcoma

Uterine Serous Carcinoma

Other rare uterine cancers (Choriocarcinoma, Yolk Sac, Neuroendocrine)

Section 3 – Cervical Cancer

High Grade Neuroendocrine Carcinoma

Other rare cervical cancers (Verrucous Carcinoma, Clear Cell Carcinoma, Adenoid Cystic Carcinoma, Rhabdomyosarcoma)

Section 4 – Vulvovaginal Cancers

Clear Cell Carcinoma

Melanoma

Bartholin Gland Carcinoma

Benign and Malignant Paget’s Disease

Other rare vulvovaginal carcinomas (Verrucous Carcinoma, Embryonal Rhabdomyosarcoma, Yolk Sac Tumor, Aggressive Angiomyxoma, Sarcomas

Section 5 – Trophoblastic Disease

Gestational Trophoblastic Disease and Placental Site Trophoblastic Tumor

Contributor Information: Please list names/affiliations of any contributors (can be tentative):

Section 1 – Ovarian Cancer

Malignant Germ Cell Tumors

Sex Cord-Stromal Tumors

Malignant Mixed Mesodermal Tumor

Clear Cell Carcinoma

Mucinous Carcinomas

Low-Grade Serous Tumors (MPSC) and Variants

Small Cell (hypercalcemic)

Other rare ovarian cancers (Small Cell Carcinoma (hypercalcemic), Small Cell Carcinoma (Neuroendocrine, Mesolthelioma, Squamous Cell, Sarcomas)

Section 2 – Uterine Cancer

Leiomyosarcoma

Other sarcomas of the uterus (Endometrial Stromal Sarcoma, STUMP, adenosarcoma)

Carcinosarcoma

Uterine Serous Carcinoma

Other rare uterine cancers (Choriocarcinoma, Yolk Sac, Neuroendocrine)

Section 3 – Cervical Cancer

High Grade Neuroendocrine Carcinoma

Other rare cervical cancers (Verrucous Carcinoma, Clear Cell Carcinoma, Adenoid Cystic Carcinoma, Rhabdomyosarcoma)

Section 4 – Vulvovaginal Cancers

Clear Cell Carcinoma

Melanoma

Bartholin Gland Carcinoma

Benign and Malignant Paget’s Disease

Other rare vulvovaginal carcinomas (Verrucous Carcinoma, Embryonal Rhabdomyosarcoma, Yolk Sac Tumor, Aggressive Angiomyxoma, Sarcomas

Section 5 – Trophoblastic Disease

Gestational Trophoblastic Disease and Placental Site Trophoblastic Tumor

Author Information

By Michael Frumovitz, MD, PhD , Professor, Gynecologic Oncology, MD Anderson Cancer Center ; Mario M. Leitao Jr., MD, Member and Fellowship Director, Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medical College. and Preetha Ramalingam, Professor, Anatomic Pathology, MD Anderson Cancer Center